GPX4 and melanoma: Targeting Glutathione peroxidase 4 (GPX4), a key enzyme that protects cells against oxidative damage, with deoxyelephantopin (DET) or DET-35 enhances the antitumor activity of vemurafenib against both vemurafenib sensitive and resistant melanoma cells [70] (Fig. 1).